Իսրայել - անգլերեն - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - treprostinil - solution for injection / infusion - treprostinil 5 mg / 1 ml - treprostinil - treprostinil s.k. is indicated for the treatment of:* primary pulmonary arterial hypertension.* pulmonary arterial hypertension associated with connective tissue disorders. * pulmonary hypertension associated with congenital systemic to pulmonary shunts.

Իսրայել - անգլերեն - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - rivaroxaban - film coated tablets - rivaroxaban 10 mg - rivaroxaban - prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery. prevention of recurrent deep vein thrombosis (dvt) and pulmonary embolism (pe), in adults (following completion of at least 6 months therapy for dvt or pe).

Իսրայել - անգլերեն - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - rivaroxaban - film coated tablets - rivaroxaban 15 mg - rivaroxaban - prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age≥75 years, diabetes mellitus, prior stroke or transient ischaemic attack. treatment of deep vein thrombosis (dvt),and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults

Իսրայել - անգլերեն - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - rivaroxaban - film coated tablets - rivaroxaban 20 mg - rivaroxaban - prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age≥75 years, diabetes mellitus, prior stroke or transient ischaemic attack. treatment of deep vein thrombosis (dvt),and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults

Իսրայել - անգլերեն - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - esomeprazole as sodium - hard capsule - esomeprazole as sodium 20 mg - esomeprazole - esoprim control 20mg is indicated for the short-term treatment of reflux symptoms (e.g. heartburn and acid regurgitation) in adults.

Իսրայել - անգլերեն - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - meropenem as trihydrate - powder for solution for inj/inf - meropenem as trihydrate 500 mg/vial - meropenem - meropenem - meropenem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - pneumonias and nosocomial pneumonias. - pulmonary infections in patients with cystic fibrosis. - urinary tract infections. - intra-abdominal infections. - gynecological infections such as endometritis and pelvic inflammatory disease. - skin and skin structure infections. - meningitis -septicemia. meropenem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. there is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency

Իսրայել - անգլերեն - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - meropenem as trihydrate - powder for solution for inj/inf - meropenem as trihydrate 1000 mg/vial - meropenem - meropenem - meropenem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - pneumonias and nosocomial pneumonias. - pulmonary infections in patients with cystic fibrosis. - urinary tract infections. - intra-abdominal infections. - gynecological infections such as endometritis and pelvic inflammatory disease. - skin and skin structure infections. - meningitis -septicemia. meropenem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. there is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency

Իսրայել - անգլերեն - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - meropenem as trihydrate - powder for solution for inj/inf - meropenem as trihydrate 1000 mg/vial - meropenem - meropenem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - pneumonias and nosocomial pneumonias. - pulmonary infections in patients with cystic fibrosis. - urinary tract infections. - intra-abdominal infections. - gynecological infections such as endometritis and pelvic inflammatory disease. - skin and skin structure infections. - meningitis -septicemia. meropenem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. there is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency

Իսրայել - անգլերեն - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - meropenem as trihydrate - powder for solution for inj/inf - meropenem as trihydrate 500 mg/vial - meropenem - meropenem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - pneumonias and nosocomial pneumonias. - pulmonary infections in patients with cystic fibrosis. - urinary tract infections. - intra-abdominal infections. - gynecological infections such as endometritis and pelvic inflammatory disease. - skin and skin structure infections. - meningitis -septicemia. meropenem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. there is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency

Իսրայել - անգլերեն - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - ceftriaxone as sodium - powder for solution for injection - ceftriaxone as sodium 1000 mg/vial - ceftriaxone - ceftriaxone s.k. is indicated for the treatment of the following infections in adults and children including term neonates (from birth): - bacterial meningitis - community acquired pneumonia - hospital acquired pneumonia - acute otitis media - intra-abdominal infections - complicated urinary tract infections (including pyelonephritis) - infections of bones and joints - complicated skin and soft tissue infections - gonorrhoea - syphilis - bacterial endocarditisceftriaxone s.k. may be used: - for treatment of acute exacerbations of chronic obstructive pulmonary disease in adults - for treatment of disseminated lyme borreliosis (early (stage ii) and late (stage iii) in adults and children including neonates from 15 days of age. - for pre-operative prophylaxis of surgical site infections - in the management of neutropenic patients with fever that is suspected to be due to a ceftriaxone – susceptible bacterial infection - in the treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above